Dr. John Joseph Evola

D.D.S. | Dentist



  
  3535 Navarre Ave, Oregon
  Ohio, 43616-3429

  419-693-0201    419-693-3170 Maps & Directions
Dr. John Joseph Evola is a Oregon, Ohio based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 3535 Navarre Ave, Oregon. Patients can reach him at 419-693-0201.
Dr. John Joseph Evola is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. John Joseph Evola speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. John Joseph Evola
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:3535 Navarre Ave, Oregon,
Ohio, 43616-3429
Phone:419-693-0201
Fax:419-693-3170
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 7315242989
Enrollment ID: I20160218001540
NPI Number: 1063627933
NPI Enumeration Date: 13 May, 2007
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 3535 Navarre Ave,
Oregon, Ohio
Zip: 43616-3429
Phone Number: 419-693-0201
Fax Number: 419-693-3170
Patients can reach Dr. John Joseph Evola at 3535 Navarre Ave, Oregon, Ohio or can call to book an appointment on 419-693-0201. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: